The Latest From CureMatch
Oncologists will be able to submit claims to payers using a Category III CPT code, paving the way for wider adoption of precision treatment options. CureMatch, Inc., a leader in precision medicine support for oncology, is pleased to announce that the American Medical Association (AMA) has issued the new Current Procedural Terminology (CPT®) Category III […]
Congratulations to CureMatch CEO Navid Alipour for being named a Top Leader of Influence in Life Science Top 50 Honoree by San Diego Business Journal. Alipour is a long-time entrepreneur in the AI space, founding multiple companies with an emphasis on the convergence of AI and the life sciences – a model now referred to […]
Dr. Link, Dr. Shlain and Mr. Simon all bring deep entrepreneurial experience in the medical and pharmaceutical fields to precision medicine. SAN DIEGO, CA, UNITED STATES, July 21, 2022 /EINPresswire.com/ — CureMatch, Inc., a leader in precision medicine support for oncology, announced today that John S. Link, MD, Jordan Shlain, MD and Greg Simon have […]
CureMatch, Inc., and Alliance Care Technologies International (ACT) have announced a strategic partnership to bring the groundbreaking CureMatch Decision Support System to a greater number of markets, particularly in the MEASA (Middle East, Asian, South Asian) region. This agreement will give more doctors and patients worldwide access to an unprecedented suite of artificial intelligence (AI)-based […]
Precision medicine tailors treatments, practices, and products to the specific needs of a patient and their condition. Dr. Kurzrock, co-founder of CureMatch recently spoke on a Clubhouse panel addressing this topic and sharing her insights. Listen Now